UCL and Eisai have signed a new agreement extendi
Author: Michael
NkGen Biotech will present Troculeucel, its cryop
Elixirgen Therapeutics has expanded its rare dise
NorthStrive Biosciences, a subsidiary of PMGC Hol
MED-EL has acquired two gene therapy programs fro
Insilico Medicine announced a strategic collabora
FDA RDEP eligibility for REP-0003 in HoFH streng
Vasily Yurenkov, founder and CEO of Greener Relo
Prema Cognition and Phoenix Community launch one
A new in vivo program could help bring regenerat